S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
NASDAQ:EVFM

Evofem Biosciences - EVFM News Today

$0.45
+0.06 (+15.52%)
(As of 08/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.37
$0.48
50-Day Range
$0.29
$1.35
52-Week Range
$0.28
$14.61
Volume
2.42 million shs
Average Volume
14.56 million shs
Market Capitalization
$5.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.35
Get Evofem Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter.

EVFM Media Mentions By Week

EVFM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVFM
News Sentiment

0.49

0.64

Average
Medical
News Sentiment

EVFM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVFM Articles
This Week

7

2

EVFM Articles
Average Week



SourceHeadline
msn.com logoEvofem Biosciences Return On Capital Employed Overview
msn.com - August 18 at 4:22 PM
MarketBeat logoEvofem Biosciences (NASDAQ:EVFM) PT Raised to $4.00 at HC Wainwright
americanbankingnews.com - August 16 at 5:48 AM
markets.businessinsider.com logo4 Analysts Have This to Say About Evofem Biosciences
markets.businessinsider.com - August 15 at 5:25 PM
finance.yahoo.com logoEvofem Biosciences to Host Investor Call on Thursday, August 11, 2022
finance.yahoo.com - August 10 at 10:11 PM
finance.yahoo.com logoTraders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier
finance.yahoo.com - August 9 at 1:28 PM
benzinga.com logoEvofem Biosciences Stock Jumps 185% Since June…Here's Why Its FDA-Approved Phexxi May Add Appreciably To Those Gains In 2/H 2022 ($EVFM)
benzinga.com - August 8 at 4:37 PM
finance.yahoo.com logoEvofem Clocks 42% Growth For Its On-Demand Birth Control Product
finance.yahoo.com - August 5 at 11:25 AM
seekingalpha.com logoEvofem stock surges 27% as Phexxi sales pick up Q/Q, net loss narrows; affirms outlook
seekingalpha.com - August 4 at 11:17 PM
finance.yahoo.com logoEvofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 Guidance
finance.yahoo.com - August 4 at 6:17 PM
finance.yahoo.com logoEvofem Biosciences Strengthens Board of Directors
finance.yahoo.com - August 3 at 11:23 AM
finance.yahoo.com logoEvofem Biosciences, Inc. CEO Saundra Pelletier Discusses Why $EVFM is a Company to Watch
finance.yahoo.com - August 1 at 12:03 PM
finance.yahoo.com logoEvofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 "EVOGUARD" Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women
finance.yahoo.com - August 1 at 12:03 PM
finance.yahoo.com logoEvofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast
finance.yahoo.com - August 1 at 12:03 PM
finance.yahoo.com logo10 Best Penny Stocks to Buy and Hold According to Reddit
finance.yahoo.com - August 1 at 12:03 PM
finance.yahoo.com logoEvofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals
finance.yahoo.com - July 29 at 10:58 AM
cnn.com logoTiny birth control stock soars following Roe v. Wade overturn
cnn.com - July 28 at 2:56 PM
finance.yahoo.com logoEvofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022
finance.yahoo.com - July 28 at 9:55 AM
finance.yahoo.com logoEvofem's House Rules Campaign Featuring Annie Murphy Receives Significant Industry Recognition
finance.yahoo.com - July 26 at 1:50 PM
finance.yahoo.com logoEvofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling
finance.yahoo.com - July 25 at 10:29 AM
finance.yahoo.com logoEvofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception Act
finance.yahoo.com - July 22 at 9:36 AM
finance.yahoo.com logoShort interests in Evofem jumps from 6% to 50% in June following the Roe v. Wade decision
finance.yahoo.com - July 21 at 8:31 PM
seekingalpha.com logoEvofem partners with a360 Media to support Phexxi prescription growth
seekingalpha.com - July 21 at 10:30 AM
finance.yahoo.com logoEvofem Partners with a360 Media to Support Phexxi® Prescription Growth
finance.yahoo.com - July 21 at 10:30 AM
finance.yahoo.com logoWall Street bet big against women’s health company after Roe v. Wade ruling
finance.yahoo.com - July 20 at 6:30 PM
seekingalpha.com logoEvofem: Desperate Times, Roe v. Wade To The Rescue?
seekingalpha.com - July 7 at 4:47 PM
seekingalpha.com logoEvofem Biosciences: An Evaluation
seekingalpha.com - July 6 at 6:25 PM
seekingalpha.com logoFemale Contraception Post Roe V. Wade - Evofem CEO Saundra Pelletier
seekingalpha.com - July 6 at 1:25 PM
benzinga.com logoThinking about buying stock in Ford Motor, Grab Holdings, Evofem Biosciences, Clovis Oncology, or Micron Technology?
benzinga.com - July 5 at 3:41 PM
msn.com logoU.S. abortion ruling ignites retail interest in women contraceptive makers - Vanda
msn.com - July 1 at 1:51 PM
benzinga.com logoThinking about buying stock in FuelCell Energy, Carnival Corp, Plug Power, Evofem Biosciences, or Revlon?
benzinga.com - June 30 at 4:29 PM
seekingalpha.com logoEvofem announces U.S. patent win for birth control method
seekingalpha.com - June 30 at 11:28 AM
finance.yahoo.com logoEvofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO
finance.yahoo.com - June 30 at 11:28 AM
barrons.com logoThinking about buying stock in Biotricity, Ford Motor, Evofem Biosciences, Nokia, or Rivian Automotive?
barrons.com - June 29 at 8:27 PM
finance.yahoo.com logo2 Contraceptive Stocks That Could Benefit Following Roe v. Wade Reversal; Analysts Say ‘Buy’
finance.yahoo.com - June 28 at 7:08 PM
markets.businessinsider.com logoEvofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi
markets.businessinsider.com - June 28 at 2:07 PM
marketwatch.com logoEvofem Shares Continue to Surge After New Deal With PBM >EVFM
marketwatch.com - June 28 at 2:07 PM
seekingalpha.com logoEvofem adds 36% on collaboration for birth control method
seekingalpha.com - June 28 at 7:21 AM
finance.yahoo.com logoEvofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi®
finance.yahoo.com - June 28 at 7:21 AM
barrons.com logoThinking about buying stock in Epizyme, Acutus Medical, Agile Therapeutics, Axsome Therapeutics, or Evofem Biosciences?
barrons.com - June 27 at 4:19 PM
markets.businessinsider.com logoCrude Oil Surges 2.5%; Evofem Biosciences Shares Jump
markets.businessinsider.com - June 27 at 4:19 PM
finance.yahoo.com logoEvofem's stock is still soaring after Friday's Supreme Court decision
finance.yahoo.com - June 27 at 4:19 PM
finance.yahoo.com logoEvofem's stock is still up after Friday's Supreme Court decision
finance.yahoo.com - June 27 at 4:19 PM
finance.yahoo.com logoEvofem's stock jumps 30% after Supreme Court decision on Roe v. Wade
finance.yahoo.com - June 24 at 4:02 PM
nasdaq.com logoEvofem Reports Post Hoc Analysis Of AMPOWER Trial Investigating Phexxi
nasdaq.com - June 18 at 8:02 AM
seekingalpha.com logoEvofem's Phexxi birth control method prevented 99% of pregnancies, post analysis shows
seekingalpha.com - June 16 at 2:40 PM
finance.yahoo.com logoPhexxi® Prevented 99% of Pregnancies Per Act of Intercourse in a Post Hoc Analysis of Phase 3 AMPOWER Clinical Trial Data
finance.yahoo.com - June 16 at 9:39 AM
finance.yahoo.com logoTraders News Source Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier
finance.yahoo.com - June 7 at 8:36 AM
finance.yahoo.com logoUS Food and Drug Administration Extends Phexxi® Shelf Life to Four Years
finance.yahoo.com - June 2 at 3:55 PM
msn.com logoWhy Evofem Biosciences Shares Are Getting Hammered Today
msn.com - May 20 at 3:39 PM
seekingalpha.com logoEvofem Biosciences stock plunges on raising $26.6M capital
seekingalpha.com - May 20 at 10:10 AM
Get Evofem Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:EVFM) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.